Clinical Laboratory Improvement Advisory Committee, 3307 [06-518]
Download as PDF
<![CDATA[
3307
Federal Register / Vol. 71, No. 13 / Friday, January 20, 2006 / Notices
academic, and private research and
commercial organizations in tracking
changes in trends of vital events.
Respondents for the National Vital
Statistics Report form (CDC 64.146) are
registration officials in each State and
Territory, the District of Columbia, and
New York City. In addition, 33 local
(county) officials in New Mexico who
record marriages occurring in each
county of New Mexico will use this
form. The data are routinely available in
each reporting office as a by-product of
ongoing activities. This form is designed
to collect counts of monthly occurrences
of births, deaths, infant deaths,
marriages, and divorces immediately
following the month of occurrence.
The Annual Marriage and Divorce
Occurrence Report form (CDC 64.147)
collects final annual counts of marriages
and divorces by month for the United
States and for each State. The statistical
counts requested on this form differ
from provisional estimates obtained on
the National Vital Statistics Report form
in that they represent complete and
final counts of marriages, divorces, and
annulments occurring during the
months of the prior year. These final
counts are usually available from State
or county officials about eight months
after the end of the data year. The data
are widely used by government,
academic, private research, and
commercial organizations in tracking
changes in trends of family formation
and dissolution.
Respondents for the Annual Marriage
and Divorce Occurrence Report form are
registration officials in each State, the
District of Columbia, New York City,
Guam, Puerto Rico, Virgin Islands,
Northern Marianas, and American
Samoa. The data are routinely available
in each reporting office as a by-product
of ongoing activities.
There are no costs to the respondents
other than their time. The total
estimated annualized burden hours are
208.
ESTIMATED ANNUALIZED BURDEN TABLE
No. of respondents
Respondents
CDC64.146: State and Territory registration officials ................................................
CDC64.146: New Mexico County marriage registrars ..............................................
CDC64.147: State/Territory/City registration officials ................................................
Dated: January 11, 2006.
Betsey S. Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–621 Filed 1–19–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee
wwhite on PROD1PC65 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
Name: Clinical Laboratory Improvement
Advisory Committee (CLIAC).
Times and Dates: 8:30 a.m.–5 p.m.,
February 8, 2006; 8:30 a.m.–3 p.m., February
9, 2006.
Place: Doubletree Hotel (Atlanta/
Buckhead), 3342 Peachtree Road NE.,
Atlanta, Georgia 30326, Telephone: (404)
231–1234.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This Committee is charged with
providing scientific and technical advice and
guidance to the Secretary, Department of
Health and Human Services; the Assistant
Secretary for Health; and the Director, CDC,
regarding the need for, and the nature of,
revisions to the standards under which
VerDate Aug<31>2005
16:16 Jan 19, 2006
Jkt 208001
58
33
58
clinical laboratories are regulated; the impact
on medical and laboratory practice of
proposed revisions to the standards; and the
modification of the standards to
accommodate technological advances.
Matters To Be Discussed: The agenda will
include updates from the Food and Drug
Administration, the Centers for Medicare &
Medicaid Services, and CDC; reports on
national cytology proficiency testing status
and Coordinating Council on the Clinical
Laboratory Workforce activities addressing
laboratory personnel shortages; and the role
of the public health laboratory, including
scope of services, customers, connectivity,
and preparedness.
Agenda items are subject to change as
priorities dictate.
Providing Oral or Written Comments: It is
the policy of CLIAC to accept written public
comments and provide a brief period for oral
public comments whenever possible. Oral
Comments: In general, each individual or
group requesting to make an oral
presentation will be limited to a total time of
five minutes (unless otherwise indicated).
Speakers must also submit their comments in
writing for inclusion in the meeting’s
Summary Report. To assure adequate time is
scheduled for public comments, individuals
or groups planning to make an oral
presentation should, when possible, notify
the contact person below at least one week
prior to the meeting date. Written Comments:
For individuals or groups unable to attend
the meeting, CLIAC accepts written
comments until the date of the meeting
(unless otherwise stated). However, the
comments should be received at least one
week prior to the meeting date so that the
comments may be made available to the
Committee for their consideration and public
distribution. Written comments, one hard
copy with original signature, should be
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
No. of responses
per respondent
Average burden
per response
(in hours)
12
12
1
12/60
6/60
30/60
provided to the contact person below.
Written comments will be included in the
meeting(s Summary Report.
Contact Person for Additional Information:
Devery Howerton, Acting Chief, Laboratory
Practice Standards Branch, Division Public
Health Partnerships—Laboratory Systems,
National Center for Health Marketing,
Coordinating Center for Health Information
and Service, CDC, 4770 Buford Highway NE.,
Mailstop G–23, Atlanta, Georgia 30341–3717;
telephone (770) 488–8155; fax (770) 488–
8279; or via e-mail at DHowerton@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: January 10, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 06–518 Filed 1–19–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
E:\FR\FM\20JAN1.SGM
20JAN1
]]>Agencies
[Federal Register Volume 71, Number 13 (Friday, January 20, 2006)]
[Notices]
[Page 3307]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-518]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting.
Name: Clinical Laboratory Improvement Advisory Committee
(CLIAC).
Times and Dates: 8:30 a.m.-5 p.m., February 8, 2006; 8:30 a.m.-3
p.m., February 9, 2006.
Place: Doubletree Hotel (Atlanta/Buckhead), 3342 Peachtree Road
NE., Atlanta, Georgia 30326, Telephone: (404) 231-1234.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This Committee is charged with providing scientific and
technical advice and guidance to the Secretary, Department of Health
and Human Services; the Assistant Secretary for Health; and the
Director, CDC, regarding the need for, and the nature of, revisions
to the standards under which clinical laboratories are regulated;
the impact on medical and laboratory practice of proposed revisions
to the standards; and the modification of the standards to
accommodate technological advances.
Matters To Be Discussed: The agenda will include updates from
the Food and Drug Administration, the Centers for Medicare &
Medicaid Services, and CDC; reports on national cytology proficiency
testing status and Coordinating Council on the Clinical Laboratory
Workforce activities addressing laboratory personnel shortages; and
the role of the public health laboratory, including scope of
services, customers, connectivity, and preparedness.
Agenda items are subject to change as priorities dictate.
Providing Oral or Written Comments: It is the policy of CLIAC to
accept written public comments and provide a brief period for oral
public comments whenever possible. Oral Comments: In general, each
individual or group requesting to make an oral presentation will be
limited to a total time of five minutes (unless otherwise
indicated). Speakers must also submit their comments in writing for
inclusion in the meeting's Summary Report. To assure adequate time
is scheduled for public comments, individuals or groups planning to
make an oral presentation should, when possible, notify the contact
person below at least one week prior to the meeting date. Written
Comments: For individuals or groups unable to attend the meeting,
CLIAC accepts written comments until the date of the meeting (unless
otherwise stated). However, the comments should be received at least
one week prior to the meeting date so that the comments may be made
available to the Committee for their consideration and public
distribution. Written comments, one hard copy with original
signature, should be provided to the contact person below. Written
comments will be included in the meeting(s Summary Report.
Contact Person for Additional Information: Devery Howerton,
Acting Chief, Laboratory Practice Standards Branch, Division Public
Health Partnerships--Laboratory Systems, National Center for Health
Marketing, Coordinating Center for Health Information and Service,
CDC, 4770 Buford Highway NE., Mailstop G-23, Atlanta, Georgia 30341-
3717; telephone (770) 488-8155; fax (770) 488-8279; or via e-mail at
DHowerton@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: January 10, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 06-518 Filed 1-19-06; 8:45 am]
BILLING CODE 4163-18-P
